Yaron Samid 🇮🇱🇺🇸

Pioneering individualized medicine at the speed of AI

Dimer Health is a virtual medical practice of Transitional Care Specialists dedicated to closing one of healthcare’s most critical gaps: the time after a patient is discharged from a medical facility. Founded by ER-trained licensed medical providers, our team understands just how vulnerable patients are during the post-discharge window, and how often they fall through the cracks. We provide 24/7 virtual care immediately after hospital or medical facility discharge, following surgery, or after an emergency room visit. Through our proactive, physician-led model, patients receive continuous follow-up, medication reconciliation, remote monitoring, lab and imaging coordination, and direct access to a clinical team that’s available day or night. For patients, Dimer Health means greater peace of mind, faster recovery, and fewer unnecessary trips back to the hospital. For providers and surgeons, it’s a way to extend care beyond the walls of their practice, without adding to their workload. For hospitals and health systems, we serve as a partner in reducing readmissions, improving throughput, and elevating patient satisfaction. And for payors, Dimer Health delivers measurable cost savings by preventing complications, closing care gaps, and supporting value-based care delivery. We work alongside clinical teams - never as a replacement, always as a trusted extension. Our mission is simple: help patients recover safely at home while supporting the providers and systems that care for them.

Cellular Intelligence is an AI-native TechBio company building the first universal virtual cell- signaling model to decode and control the complex language of cells. Using our proprietary capsule technology, we generate dynamic cellular data at over 1,000x higher efficiency than existing methods. We train large-scale predictive models on this data to design and optimize regenerative medicine protocols, predict drug responses, and model disease mechanisms. Cellular Intelligence is based in Boston and founded by leading AI entrepreneurs and world-class scientists, engineers, and operators. We are backed by over $62 million from investors like Khosla Ventures and the Chan Zuckerberg Initiative. Follow along as we accelerate breakthroughs across human health.

Knock allows your prospects to start Slack conversations with your sales from anywhere. Remove the barriers of forms and website chatbots while cutting costs and shortening the sales cycle. #FormsAreDead

Leo™️ is the world’s first AI for Mechanical Engineering, empowering MechEs to connect directly with their CAD, PDM, and engineering data without compromising security. Leo delivers accurate, context-aware answers, helps you find and reuse parts instantly, and lets you explore early design ideas with fast 3D concept models. Built on our proprietary Large Mechanical Model (LMM), Leo understands geometry, specifications, technical documentation, and assemblies - making the design process faster, more precise, and consistent. Leading AI researchers and mechanical engineers from MIT, Technion, Microsoft, and Elbit Systems founded Leo in 2023.

Through innovation and foresight, we envision a world where financial opportunities are boundless and accessible to all. Our forward-looking approach seeks to redefine the financial landscape, dismantling obstacles and creating pathways to financial well-being for individuals and communities alike. We strive to revolutionize the way people interact with money, empowering them with knowledge, support, and possibilities previously thought unattainable.

Helping make life a little easier by enabling and increasing financial inclusion in emerging markets through technology.

Together AI is the AI Native Cloud, purpose-built for AI engineers and researchers with a full suite of tooling across inference, model shaping, and pre-training. AI natives can use Together AI as a full-stack AI platform — from a high- performance inference engine built for reliable and fast scaling to on-demand GPU clusters and massive-scale AI factories. Together AI continuously pushes the frontier forward by productizing cutting-edge research from our world-leading AI systems research team. By combining research velocity with production-grade infrastructure, we enable companies to reliably scale AI-native applications as fast as the field evolves. Trusted by leading AI natives like Cursor, Decagon, Eleven Labs, AI21, Hedra, and Cartesia, as well as SaaS innovators such as Salesforce, Zoom, and Zomato, Together AI powers the next generation of AI-native applications.

Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patients neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.

Hi, were Descope! Our no / low code workflows, SDKs, and APIs help organizations create and customize identity journeys for their customers, partners, AI agents, and MCP servers. Organizations like GoFundMe, Databricks, GoodRx, Navan, and You.com use Descope to reduce user friction, stop account takeover attacks, and get a 360 degree view of their customer and agentic identities.

We are on a mission to make product design painless through acceleration of designers and empowerment of product managers and other stakeholders.

Coho AI is a product-led revenue platform that enables companies to maximize the revenue potential of their user base. Putting data insights at the forefront of decision-making, Coho AI equips go-to-market and growth teams with the tools they need to identify, predict, and prioritize key conversion opportunities. Our platform fosters automated customer interactions and provides real-time visibility to your book of business. Capitalizing on product usage data, intelligent segmentation, and user journeys, Coho AI transforms how SaaS companies manage their self-service conversion and pipeline, driving maximum revenue.

Create and manage GPT Agents that users love and you trust. 🤖❤️ OneAIs platform empowers you to gracefully steer conversations toward your goals 🎯, ensuring users enjoy accurate, brand-aligned interactions, whether via chat 💬, voice 🎙, or phone 📞. It offers instant deployment on your website or app, robust analytics, and seamless integration with your systems. Visit oneai.com to create your 1st agent or book a demo.

Nas means people – and we, as Nas Company, are on a mission to build community products that bring people together! From the early days of Nas Daily, our mission has been to form communities around the world. We believe that people learn better in communities. People can do more together. People can find mentors, coaches, thought leaders, and friends in communities. A strong community is worth a thousand marketing campaigns. Nas.io is building products for Community Builders, Brands, Content Creators, DAO builders, and anyone who also wants to bring people together. We have built tools and integrations that will let you start and manage an engaged community. As a company, we’ve successfully built communities over and over again – and now, we are building tools and integrations that will allow other people to build communities faster than ever before.

Pioneering individualized medicine at the speed of AI

Dimer Health is a virtual medical practice of Transitional Care Specialists dedicated to closing one of healthcare’s most critical gaps: the time after a patient is discharged from a medical facility. Founded by ER-trained licensed medical providers, our team understands just how vulnerable patients are during the post-discharge window, and how often they fall through the cracks. We provide 24/7 virtual care immediately after hospital or medical facility discharge, following surgery, or after an emergency room visit. Through our proactive, physician-led model, patients receive continuous follow-up, medication reconciliation, remote monitoring, lab and imaging coordination, and direct access to a clinical team that’s available day or night. For patients, Dimer Health means greater peace of mind, faster recovery, and fewer unnecessary trips back to the hospital. For providers and surgeons, it’s a way to extend care beyond the walls of their practice, without adding to their workload. For hospitals and health systems, we serve as a partner in reducing readmissions, improving throughput, and elevating patient satisfaction. And for payors, Dimer Health delivers measurable cost savings by preventing complications, closing care gaps, and supporting value-based care delivery. We work alongside clinical teams - never as a replacement, always as a trusted extension. Our mission is simple: help patients recover safely at home while supporting the providers and systems that care for them.

Much more than just a football club.

Cellular Intelligence is an AI-native TechBio company building the first universal virtual cell- signaling model to decode and control the complex language of cells. Using our proprietary capsule technology, we generate dynamic cellular data at over 1,000x higher efficiency than existing methods. We train large-scale predictive models on this data to design and optimize regenerative medicine protocols, predict drug responses, and model disease mechanisms. Cellular Intelligence is based in Boston and founded by leading AI entrepreneurs and world-class scientists, engineers, and operators. We are backed by over $62 million from investors like Khosla Ventures and the Chan Zuckerberg Initiative. Follow along as we accelerate breakthroughs across human health.